Experimental exercise/metabolic compounds
SLU-PP-332 vs BAM15
Both are non-peptide preclinical compounds with distinct mechanisms: ERR agonism versus mitochondrial uncoupling.
At a glance
SLU-PP-332
BAM15
Human evidence
No therapeutic human administration evidence identified. A 2026 human-liver S9 study addresses metabolism/detection, not clinical exposure.
No therapeutic human trial evidence was identified.
Research focus
Exercise-mimetic, metabolism and obesity research
Obesity, insulin resistance and metabolic research
Regulatory status
No FDA/EMA-approved medicine identified.
No FDA/EMA-approved medicine identified.
Route / formulation
This is a small molecule, not a peptide. Oral commercial capsules are not validated by preclinical papers.
This is not a peptide; commercial oral products have no established clinical validation.
No human head-to-head or therapeutic human evidence Both are non-peptide preclinical compounds with distinct mechanisms: ERR agonism versus mitochondrial uncoupling.